Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.
Since Nov 18, 2025
Transactions
51
Purchases
5
Sales
46
Purchase value
$82.55M
Sale value
$15.80M
Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.
Adrian RawcliffeDirector
4Rule 10b5-1 plan disclosed
Filed Aug 13, 2026Period of report Aug 12, 20260001193125-26-349962
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 12, 2026
Common StockF1F2
12,700
$5.29
$67.18K
0
Direct
Filing footnotes · 2
F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
F2The price reflected is the weighted-average sale price for stock sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $5.16 to $5.42 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Filed Aug 13, 2026Period of report Aug 11, 20260001193125-26-349963
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 11, 2026
Common StockF1
7,000
$6.01
$42.07K
44,930
Direct
Filing footnotes · 2
F1The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
Filed Aug 13, 2026Period of report Aug 11, 20260001193125-26-349961
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 11, 2026
Common StockF1F2
3,864
$6.01
$23.22K
20,079
Direct
Filing footnotes · 4
F1On August 11, 2026, the reporting person sold 3,864 shares of common stock solely to cover taxes associated with the vesting of restricted stock units on August 11, 2026. These sales were made pursuant to a previously adopted 10b5-1 Trading Plan.
F2The price reflected is the weighted-average sale price for stock sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $6.01 to $6.03 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3Includes an aggregate of (i) 6,107,593 shares of common stock held by SNBL USA, Ltd. ("SNBL USA") and (ii) 3,498,815 shares of common stock held by Shin Nippon Biomedical Laboratories, Ltd. ("SNBL").
F4Ken Takanashi, a director of the Issuer, is a director of SNBL USA and SNBL and Mr. Takanashi may be deemed to beneficially own the reported securities held by SNBL USA and SNBL. Pursuant to Rule 16a-1 under the Securities Exchange Act of 1934, as amended (the "Act"), Mr. Takanashi disclaims beneficial ownership of the reported securities held by SNBL USA and SNBL, except to the extent of his pecuniary interest therein. The filing of this Form 4 shall not be construed as an admission that Mr. Takanashi is or was for the purposes of Section 16(a) of the Act, or otherwise, the beneficial owner of any of the reported securities held by SNBL USA or SNBL.
Filed Aug 13, 2026Period of report Aug 11, 20260001193125-26-349960
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 11, 2026
Common StockF1
432
$6.01
$2.60K
24,968
Direct
Filing footnotes · 1
F1On August 11, 2026, the reporting person sold 432 shares of common stock solely to cover taxes associated with the vesting of restricted stock units on August 11, 2026. These sales were made pursuant to a previously adopted 10b5-1 Trading Plan.
Filed Mar 30, 2026Period of report Mar 26, 20260001231919-26-000297
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseMar 30, 2026
Ordinary SharesF6F2F3
971,091
$6.50
$6.31M
26,975,505
IndirectSee footnotes
PurchaseMar 27, 2026
Ordinary SharesF5F2F3
2,495,623
$6.43
$16.05M
26,004,414
IndirectSee footnotes
PurchaseMar 26, 2026
Ordinary SharesF1F2F3
4,954,558
$6.06
$30.02M
23,157,567
IndirectSee footnotes
PurchaseMar 26, 2026
Ordinary SharesF4F2F3
351,224
$6.38
$2.24M
23,508,791
IndirectSee footnotes
Filing footnotes · 8
F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.365 to $6.36 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.
F3Held directly by the Fund.
F4The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.365 to $6.40 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F5The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.09 to $6.74 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F6The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.305 to $6.665 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F7Represents previously reported restricted stock unit awards ("RSUs") granted to Dr. Kolchinsky and shares received by Dr. Kolchinsky upon settlement of RSUs.
F8Dr. Kolchinsky is a Managing Partner of the Adviser who serves on the Issuer's board of directors. Under Dr. Kolchinsky's arrangement with the Adviser, Dr. Kolchinsky holds the RSUs and shares for the benefit of the Fund. Dr. Kolchinsky is obligated to turn over to the Adviser any net cash or shares received upon settlement of the RSUs, which will offset advisory fees owed by the Fund to the Adviser.
Filed Feb 27, 2026Period of report Feb 26, 20260001193125-26-083712
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 26, 2026
Ordinary SharesF1F4
17,900
$15.094
$270.18K
61,867
Direct
SaleFeb 26, 2026
Ordinary SharesF1
15,294
$15.00
$229.41K
61,867
Direct
Filing footnotes · 4
F1The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2025.
F2The option vests as to 25% of the shares on February 5, 2025, and vests as to an additional 6.25% of the shares quarterly thereafter until February 5, 2028.
F3The option vests as to 25% of the shares on February 17, 2024 and vests as to an additional 6.25% of the shares quarterly thereafter until February 17, 2027.
F4The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $15.00 to $15.10 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Filed Feb 11, 2026Period of report Feb 5, 20260001193125-26-047323
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 9, 2026
Ordinary SharesF3
3,588
$13.45
$48.26K
134,385
Direct
Filing footnotes · 4
F1Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2027 through February 8, 2030.
F2Includes 1,983 ordinary shares acquired on January 14, 2026, under the issuer's 2019 Employee Share Purchase Plan.
F3On February 9, 2026, the reporting person sold 3,588 ordinary shares solely to cover taxes associated with the vesting of restricted share units ("RSUs") on February 8, 2026. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations.
F4The option vests as to 25% of the shares on February 8, 2027, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2030.
Filed Feb 11, 2026Period of report Feb 5, 20260001193125-26-047322
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 9, 2026
Ordinary SharesF2
10,480
$13.45
$140.96K
275,520
Direct
Filing footnotes · 3
F1Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2027 through February 8, 2030.
F2On February 9, 2026, the reporting person sold 10,480 ordinary shares solely to cover taxes associated with the vesting of restricted share units ("RSUs") on February 8, 2026. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations.
F3The option vests as to 25% of the shares on February 8, 2027, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2030.
Filed Feb 11, 2026Period of report Feb 5, 20260001193125-26-047319
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 9, 2026
Ordinary SharesF2
1,883
$13.45
$25.33K
61,867
Direct
Filing footnotes · 3
F1Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2027 through February 8, 2030.
F2On February 9, 2026, the reporting person sold 1,883 ordinary shares solely to cover taxes associated with the vesting of restricted share units ("RSUs") on February 8, 2026. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations.
F3The option vests as to 25% of the shares on February 8, 2027, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2030.
Filed Feb 11, 2026Period of report Feb 5, 20260001193125-26-047314
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 9, 2026
Ordinary SharesF3
3,228
$13.45
$43.42K
408,246
Direct
Filing footnotes · 4
F1Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2027 through February 8, 2030.
F2Includes 3,162 ordinary shares acquired on July 15, 2025, and January 14, 2026, under the issuer's 2019 Employee Share Purchase Plan.
F3On February 9, 2026, the reporting person sold 3,228 ordinary shares solely to cover taxes associated with the vesting of restricted share units ("RSUs") on February 8, 2026. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations.
F4The option vests as to 25% of the shares on February 8, 2027, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2030.
Filed Jan 6, 2026Period of report Jan 2, 20260001193125-26-005195
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 2, 2026
Ordinary SharesF1F3
8,080
$15.92
$128.63K
26,295
Direct
SaleJan 2, 2026
Ordinary SharesF1F4
1,295
$16.70
$21.63K
25,000
Direct
Filing footnotes · 4
F1The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2025.
F2These share options are fully vested.
F3The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $15.56 to $16.54 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F4The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $16.61 to $16.79 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Filed Dec 10, 2025Period of report Dec 8, 20250001193125-25-314736
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 9, 2025
Ordinary SharesF1F6
36
$20.25
$729.00
89,218
Direct
SaleDec 9, 2025
Ordinary SharesF1F6F7
50,000
$20.025
$1.00M
90,365
Direct
SaleDec 8, 2025
Ordinary SharesF1
60,000
$13.20
$792.00K
89,218
Direct
SaleDec 8, 2025
Ordinary SharesF1F4
50,000
$15.00
$750.00K
139,218
Direct
SaleDec 8, 2025
Ordinary SharesF1
50,000
$13.20
$660.00K
89,218
Direct
SaleDec 8, 2025
Ordinary SharesF1
50,000
$18.00
$900.00K
89,218
Direct
Filing footnotes · 7
F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.
F2These share options are fully vested.
F3The share option represented a right to purchase a total of 175,000 ordinary shares that vest as to 25% of the shares on January 1, 2023 and vests as to an additional 6.25% of the shares quarterly thereafter until January 1, 2026.
F4The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $15.00 to $15.045 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F5The share option represented a right to purchase a total of 272,200 ordinary shares that vest as to 25% of the shares on February 17, 2024 and vests as to an additional 6.25% of the shares quarterly thereafter until February 17, 2027.
F6The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $20.00 to $20.22 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F7Includes 1,147 ordinary shares acquired on July 14, 2025, under the issuer's 2019 Employee Share Purchase Plan.
Filed Dec 10, 2025Period of report Dec 8, 20250001193125-25-314742
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 8, 2025
Ordinary SharesF1
42,000
$15.00
$630.00K
12,700
Direct
Filing footnotes · 2
F1The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2025.
Filed Dec 10, 2025Period of report Dec 8, 20250001193125-25-314741
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 8, 2025
Ordinary SharesF1
7,000
$13.00
$91.00K
44,930
Direct
SaleDec 8, 2025
Ordinary SharesF1
7,000
$14.00
$98.00K
44,930
Direct
Filing footnotes · 2
F1The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.
Filed Dec 10, 2025Period of report Dec 8, 20250001193125-25-314740
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 8, 2025
Ordinary SharesF1
6,445
$12.75
$82.17K
12,700
Direct
SaleDec 8, 2025
Ordinary SharesF1
42,000
$12.75
$535.50K
12,700
Direct
SaleDec 8, 2025
Ordinary SharesF1F3
15,000
$14.07
$211.05K
12,700
Direct
SaleDec 8, 2025
Ordinary SharesF1F4
30,000
$18.02
$540.60K
12,700
Direct
Filing footnotes · 4
F1The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025.
F2These share options are fully vested.
F3The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $14.00 to $14.14 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F4The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $18.00 to $18.19 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Filed Dec 10, 2025Period of report Dec 8, 20250001193125-25-314739
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 8, 2025
Ordinary SharesF1
7,494
$12.75
$95.55K
32,894
Direct
SaleDec 8, 2025
Ordinary SharesF1
7,494
$15.00
$112.41K
25,400
Direct
SaleDec 8, 2025
Ordinary SharesF1
15,000
$12.75
$191.25K
42,630
Direct
SaleDec 8, 2025
Ordinary SharesF1
17,230
$15.00
$258.45K
25,400
Direct
SaleDec 8, 2025
Ordinary SharesF1
20,000
$12.75
$255.00K
50,400
Direct
SaleDec 8, 2025
Ordinary SharesF1
25,000
$15.00
$375.00K
25,400
Direct
SaleDec 8, 2025
Ordinary SharesF1
21,000
$12.75
$267.75K
25,400
Direct
SaleDec 8, 2025
Ordinary SharesF1
21,000
$12.75
$267.75K
25,400
Direct
Filing footnotes · 2
F1The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025.
Filed Dec 10, 2025Period of report Dec 8, 20250001193125-25-314738
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 8, 2025
Ordinary SharesF1F2
12,020
$13.09
$157.34K
283,197
Direct
SaleDec 8, 2025
Ordinary SharesF1F3
7,980
$14.05
$112.12K
275,217
Direct
Filing footnotes · 3
F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.
F2The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $12.75 to $13.74 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $13.75 to $14.70 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price
Filed Dec 10, 2025Period of report Dec 8, 20250001193125-25-314737
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 8, 2025
Ordinary SharesF1
28,125
$14.50
$407.81K
25,000
Direct
SaleDec 8, 2025
Ordinary SharesF1F4
107,400
$14.556
$1.56M
25,000
Direct
SaleDec 8, 2025
Ordinary SharesF1
45,882
$14.50
$665.29K
25,000
Direct
SaleDec 8, 2025
Ordinary SharesF1
9,375
$15.00
$140.63K
25,000
Direct
SaleDec 8, 2025
Ordinary SharesF1
37,500
$14.08
$528.00K
25,000
Direct
SaleDec 8, 2025
Ordinary SharesF1
17,900
$15.00
$268.50K
25,000
Direct
SaleDec 8, 2025
Ordinary SharesF1F6
122,349
$14.195
$1.74M
25,000
Direct
SaleDec 8, 2025
Ordinary SharesF1
50,000
$16.00
$800.00K
25,000
Direct
SaleDec 8, 2025
Ordinary SharesF1
22,500
$14.08
$316.80K
25,000
Direct
Filing footnotes · 7
F1The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2025.
F2The share option represented a right to purchase a total of 150,000 ordinary shares that vest as to 25% of the shares on January 1, 2023 and vests as to an additional 6.25% of the shares quarterly thereafter until January 1, 2026.
F3The share option represented a right to purchase a total of 286,400 ordinary shares that vest as to 25% of the shares on February 5, 2025, and vests as to an additional 6.25% of the shares quarterly thereafter until February 5, 2028.
F4The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $14.50 to $14.78 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F5The share option represented a right to purchase a total of 244,700 ordinary shares that vest as to 25% of the shares on February 17, 2024 and vests as to an additional 6.25% of the shares quarterly thereafter until February 17, 2027.
F6The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $14.08 to $15.00 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Filed Dec 10, 2025Period of report Dec 8, 20250001193125-25-314735
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleDec 8, 2025
Ordinary SharesF1F2
9,600
$13.09
$125.66K
35,330
Direct
SaleDec 8, 2025
Ordinary SharesF1F3
6,515
$14.065
$91.63K
28,815
Direct
Filing footnotes · 3
F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2025.
F2The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $12.75 to $13.69 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $13.75 to $14.71 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.